about
Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: a national multi-center study.Clinical and histopathological factors associated with Ki-67 expression in breast cancer patients.Is administration of trastuzumab an independent risk factor for developing osteonecrosis of the jaw among metastatic breast cancer patients under zoledronic acid treatment?Coverage of axillary lymph nodes with high tangential fields in breast radiotherapy.Implantation of fiducial markers for image guidance in prostate radiotherapy: patient-reported toxicity.Impact of percent positive random biopsies on biochemical outcome in prostate cancer patients treated with external beam radiotherapy with or without androgen deprivation.Stereotactic vacuum-assisted core biopsy results for non-palpable breast lesions.Bioelectrical impedance for detecting and monitoring lymphedema in patients with breast cancer. Preliminary results of the florence nightingale breast study group.The application of positron emission tomography/computed tomography in radiation treatment planning: effect on gross target volume definition and treatment managementDosimetric comparison of field in field intensity-modulated radiotherapy technique with conformal radiotherapy techniques in breast cancerInsufficiency fractures after pelvic radiotherapy in patients with prostate cancerDosimetric comparison of intensity modulated pelvic radiotherapy with 3D conformal radiotherapy in patients with gynecologic malignanciesAre the standard tangential breast irradiation fields used in the ACOSOG Z0011 trial really covering the entire axilla?Prognostic Significance of Adjuvant Chemotherapy Induced Amenorrhea in Luminal A and B SubtypesThe Effect of Mini-Latissimus Dorsi Flap (MLDF) Reconstruction on Shoulder Function in Breast Cancer PatientsVitamin D levels in patients with breast cancer: importance of dressing style
P50
Q33414118-6A5C73E6-38F6-470C-B67F-A2E2FEB59DDCQ35042063-26F11BD2-6F86-4FA2-A09E-B59F28516DAAQ35624101-1634931E-C153-4328-B70E-B502FF07E431Q36324493-2B7650D0-3FA4-4371-9C77-898BCAEC053EQ40387434-9E25D015-24D5-4DC8-9C20-F78C233F1084Q43696046-3B79C9D1-9CB3-4831-BC52-8F88AA4526AFQ48846405-A303761E-DF2B-42C7-A003-5BC16B5BCDEFQ51068062-C395F202-E125-4B4D-9FE6-55BB6B6255F1Q82708814-BCE5804B-0B25-46C3-BF21-03A8F7A5CDA6Q84330088-6C248738-E2A9-4CF6-9577-41651958911BQ84823789-4745C244-062E-4618-8FD1-8A8B4DCA04F7Q84868568-209541C7-73B2-4657-882D-E440101B337AQ85648317-10532049-2AD0-4293-9F12-8B2F00D4F7AAQ91032767-97E2AE99-E180-49FC-8239-45FA6A11E43FQ91943860-5989AF4D-C3D6-468A-8230-282C66ECC403Q95563343-5354EF86-62B1-48BA-855C-D2D945664CDC
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
G Alço
@en
G Alço
@nl
type
label
G Alço
@en
G Alço
@nl
prefLabel
G Alço
@en
G Alço
@nl
P31
P496
0000-0002-3592-9923